Effects of trans-10,cis-12 conjugated linoleic acid on body composition in genetically obese mice

Journal of Medicinal Food

Volumn 12, Issue 1, 2009, Pages 56-63

  Hur, Sunjin ^a   Whitcomb, Faith ^a   Rhee, Siyeon ^a   Park, Yooheon ^a   Good, Deborah J ^b   Park, Yeonhwa ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Adipose tissue; CLA (conjugated linoleic acid); Leptin; Nhlh2 knockout mice

Indexed keywords

CHOLESTEROL; CONJUGATED LINOLEIC ACID; HELIX LOOP HELIX PROTEIN; LEPTIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY FAT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG ACTIVITY; FEMALE; FOOD INTAKE; KNOCKOUT MOUSE; LIPID DIET; LIPID METABOLISM; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SITTING; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; WILD TYPE;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; DIETARY SUPPLEMENTS; ENERGY INTAKE; FEMALE; LEPTIN; LINOLEIC ACIDS, CONJUGATED; MICE; MICE, KNOCKOUT; MICE, OBESE; OBESITY; TRIGLYCERIDES;

ANIMALIA; GLYCINE MAX; MUS;

EID: 64949094084     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2008.0110     Document Type: Article

References (60)

1. Park Y, Pariza MW: Mechanisms of body fat modulation by conjugated linoleic acid (CLA). Food Res Int 2007;40:311-323.
2. Pariza MW: Perspective on the safety and effectiveness of conjugated linoleic acid. Am J Clin Nutr 2004;79(Suppl): 1132S-1136S.
3. Kepler CR, Hirons KP, McNeill JJ, Tove SB: Intermediates and products of the biohydrogenation of linoleic acid by Butyrinvib-rio fibrisolvens. J Biol Chem 1966;241:1350-1354.
4. Griinari JM, Corl BA, Lacy SH, Chouinard PY, Nurmela KV, Bauman DE: Conjugated linoleic acid is synthesized endogenously in lactating dairy cows by delta(9)-desaturase. J Nutr 2000;130:2285-2291.
5. Park Y, Pariza MW: Evidence that commercial calf and horse sera can contain substantial amounts of trans-10,cis-12 conjugated linoleic acid. Lipids 1998;33:817-819.
6. Dhiman TR, Zaman S, Olson KC, Bingham HR, Ure AL, Pariza MW: Influence of feeding soybean oil on conjugated linoleic acid content in beef. J Agric Food Chem 2005;53:684-689.
7. Ip C, Dong Y, Ip MM, Banni S, Carta G, Angioni E, Murru E, Spada S, Melis MP, Saebo A: Conjugated linoleic acid isomers and mammary cancer prevention. Nutr Cancer 2002;43:52-58.
8. Masso-Welch PA, Zangani D, Ip C, Vaughan MM, Shoemaker SF, McGee SO, Ip MM: Isomers of conjugated linoleic acid differ in their effects on angiogenesis and survival of mouse mammary adipose vasculature. J Nutr 2004;134:299-307.
9. Masso-Welch PA, Zangani D, Ip C, Vaughan MM, Shoemaker S, Ramirez RA, Ip MM: Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid. Cancer Res 2002;62:4383-4389.
10. Park Y, Storkson JM, Ntambi JM, Cook ME, Sih CJ, Pariza MW: Inhibition of hepatic stearoyl-CoA desaturase activity by trans10, cis-12 conjugated linoleic acid and its derivatives. Biochim Biophys Acta 2000;1486:285-292.
11. Park Y, Storkson JM, Albright KJ, Liu W, Pariza MW: Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 1999;34:235-241.
12. Storkson JM, Park Y, Cook ME, Pariza MW: Effects of trans10,cis-12 conjugated linoleic acid (CLA) and cognates on apolipoprotein B secretion in HepG2 cells. Nutr Res 2005;25: 387-399.
13. Cook ME, Miller CC, Park Y, Pariza M: Immune modulation by altered nutrient metabolism - nutritional control of immune-induced growth depression. Poult Sci 1993;72:1301-1305.
14. Valeille K, Gripois D, Blouquit MF, Souidi M, Riottot M, Bouthegourd JC, Serougne C, Martin JC: Lipid atherogenic risk markers can be more favourably influenced by the cis-9,trans-11-octadecadienoate isomer than a conjugated linoleic acid mixture or fish oil in hamsters. Br J Nutr 2004;91:191-199.
15. Yang M, Cook ME: Dietary conjugated linoleic acid decreased cachexia, macrophage tumor necrosis factor-alpha production, and modifies splenocyte cytokines production. Exp Biol Med (Maywood) 2003;228:51-58.
16. Song HJ, Sneddon AA, Barker PA, Bestwick C, Choe SN, Mc-Clinton S, Grant I, Rotondo D, Heys SD, Wahle KW: Conjugated linoleic acid inhibits proliferation and modulates protein kinase C isoforms in human prostate cancer cells. Nutr Cancer 2004; 49:100-108.
17. Pariza MW, Park Y, Xu X, Ntambi J, Kang K: Speculation on the mechanisms of action of conjugated linoleic acid. In: Advances in Conjugated Linoleic Acid Research, Vol. 2 (Sebedio J-L, Christie WW, Adlof R, eds.). AOCS Press, Champaign, IL, 2003, pp. 251-258.
18. Weber TE, Richert BT, Belury MA, Gu Y, Enright K, Schinckel AP: Evaluation of the effects of dietary fat, conjugated linoleic acid, and ractopamine on growth performance, pork quality, and fatty acid profiles in genetically lean gilts. J Anim Sci 2006;84: 720-732.
19. Sisk MB, Hausman DB, Martin RJ, Azain MJ: Dietary conjugated linoleic acid reduces adiposity in lean but not obese Zucker rats. J Nutr 2001;131:1668-1674.
20. Arbones-Mainar JM, Navarro MA, Acin S, Guzman MA, Arnal C, Surra JC, Carnicer R, Roche HM, Osada J: Trans-10, cis-12-and cis-9, trans-11-conjugated linoleic acid isomers selectively modify HDL-apolipoprotein composition in apolipoprotein E knockout mice. J Nutr 2006;136:353-359.
21. Ohashi A, Matsushita Y, Kimura K, Miyashita K, Saito M: Conjugated linoleic acid deteriorates insulin resistance in obese/diabetic mice in association with decreased production of adiponectin and leptin. J Nutr Sci Vitaminol (Tokyo) 2004;50: 416-421.
22. Houseknecht KL, Vanden Heuvel JP, Moya-Camarena SY, Portocarrero CP, Peck LW, Nickel KP, Belury MA: Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun 1998;244:678-682.
23. Wendel AA, Purushotham A, Liu LF, Belury MA: Conjugated linoleic acid fails to worsen insulin resistance but induces hepatic steatosis in the presence of leptin in ob/ob mice. J Lipid Res 2008;49:98-106.
24. Coyle CA, Jing E, Hosmer T, Powers JB, Wade G, Good DJ: Reduced voluntary activity precedes adult-onset obesity in Nhlh2 knockout mice. Physiol Behav 2002;77:387-402.
25. Jing E, Nillni EA, Sanchez VC, Stuart RC, Good DJ: Deletion of the Nhlh2 transcription factor decreases the levels of the anorexigenic peptides alpha melanocyte-stimulating hormone and thyrotropin-releasing hormone and implicates prohormone convertases I and II in obesity. Endocrinology 2004;145:1503-1513.
26. Good DJ, Porter FD, Mahon KA, Parlow AF, Westphal H, Kirsch IR: Hypogonadism and obesity in mice with a targeted deletion of the Nhlh2 gene. Nat Genet 1997;15:397-401.
27. th ed. (Helrich K, ed.). Association of Official Analytical Chemists, Arlington, VA, 1990, pp. 935-937.
28. Good DJ: How tight are your genes? Transcriptional and post-transcriptional regulation of the leptin receptor, NPY, and POMC genes. Horm Behav 2000;37:284-298.
29. Park Y, Albright KJ, Storkson JM, Liu W, Pariza MW: Conjugated linoleic acid (CLA) prevents body fat accumulation and weight gain in an animal model. J Food Sci 2007;72: S612-S617.
30. Park Y, Albright KJ, Liu W, Storkson JM, Cook ME, Pariza MW: Effect of conjugated linoleic acid on body composition in mice. Lipids 1997;32:853-858.
31. West DB, Delany JP, Camet PM, Blohm F, Truett AA, Scimeca J: Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am J Physiol 1998;275:R667-R672.
32. Rahman MM, Bhattacharya A, Banu J, Fernandes G: Conjugated linoleic acid protects against age-associated bone loss in C57BL/6 female mice. J Nutr Biochem 2007;18:467-474.
33. Belury MA, Kempa-Steczko A: Conjugated linoleic acid modulates hepatic lipid composition in mice. Lipids 1997;32:199-204.
34. Wahle KW, Heys SD, Rotondo D: Conjugated linoleic acids: are they beneficial or detrimental to health? Prog Lipid Res 2004; 43:553-587.
35. Pariza MW, Park Y, Cook ME: The biologically active isomers of conjugated linoleic acid. Prog Lipid Res 2001;40:283-298.
36. Tsuboyama-Kasaoka N, Takahashi M, Tanemura K, Kim HJ, Tange T, Okuyama H, Kasai M, Ikemoto S, Ezaki O: Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 2000;49: 1534-1542.
37. Cao ZP, Wang F, Xiang XS, Cao R, Zhang WB, Gao SB: Intracerebroventricular administration of conjugated linoleic acid (CLA) inhibits food intake by decreasing gene expression of NPY and AgRP. Neurosci Lett 2007;418:217-221.
38. Kritchevsky D, Tepper SA, Wright S, Tso P, Czarnecki SK: Influence of conjugated linoleic acid (CLA) on establishment and progression of atherosclerosis in rabbits. J Am Coll Nutr 2000;19(Suppl):472S-477S.
39. Navarro V, Miranda J, Churruca I, Fernandez-Quintela A, Rodriguez VM, Portillo MP: Effects of trans-10,cis-12 conjugated linoleic acid on body fat and serum lipids in young and adult hamsters. J Physiol Biochem 2006;62:81-87.
40. Bissonauth V, Chouinard Y, Marin J, Leblanc N, Richard D, Jacques H: The effects of t10,c12 CLA isomer compared with c9,t11 CLA isomer on lipid metabolism and body composition in hamsters. J Nutr Biochem 2006;17:597-603.
41. Wilson TA, Nicolosi RJ, Saati A, Kotyla T, Kritchevsky D: Conjugated linoleic acid isomers reduce blood cholesterol levels but not aortic cholesterol accumulation in hypercholesterolemic hamsters. Lipids 2006;41:41-48.
42. Gavino VC, Gavino G, Leblanc MJ, Tuchweber B: An isomeric mixture of conjugated linoleic acids but not pure cis-9, trans-11-octadecadienoic acid affects body weight gain and plasma lipids in hamsters. J Nutr 2000;130:27-29.
43. Tricon S,Yaqoob P: Conjugated linoleic acid and human health: a critical evaluation of the evidence. Curr Opin Clin Nutr Metab Care 2006;9:105-110.
44. Riserus U, Vessby B, Arner P, Zethelius B: Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity. Diabetologia 2004;47:1016-1019.
45. Riserus U, Arner P, Brismar K, Vessby B: Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 2002;25:1516-1521.
46. Riserus U, Vessby B, Arnlov J, Basu S: Effects of cis-9,trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr 2004;80:279-283.
47. Moloney F, Yeow TP, Mullen A, Nolan JJ, Roche HM: Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr 2004;80:887-895.
48. Dumke CL, Gazdag AC, Fechner K, Park Y, Pariza MW, Cartee GD: Skeletal muscle glucose transport in conjugated linoleic acid (CLA) fed mice. Med Sci Sports Exercise 2000;32(Suppl): S226.
49. Hamura M, Yamatoya H, Kudo S: Glycerides rich in conjugated linoleic acid (CLA) improve blood glucose control in diabetic C57BLKS-leprdb/leprdb mice. J Oleo Sci 2001;50: 889-894.
50. Wargent E, Sennitt MV, Stocker C, Mayes AE, Brown L, O'-Dowd J, Wang S, Einerhand AW, Mohede I, Arch JR, Cawthorne MA: Prolonged treatment of genetically obese mice with conjugated linoleic acid improves glucose tolerance and lowers plasma insulin concentration: possible involvement of PPAR activation. Lipids Health Dis 2005;4:3.
51. O'Hagan S, Menzel A: A subchronic 90-day oral rat toxicity study and in vitro genotoxicity studies with a conjugated linoleic acid product. Food Chem Toxicol 2003;41:1749-1760.
52. Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O: Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J Nutr 2005;135:778-784.
53. Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O: Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr 2004;79:1118-1125.
54. Larsen TM, Toubro S, Gudmundsen O, Astrup A: Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat regain. Am J Clin Nutr 2006;83:606-612.
55. Whigham LD, O'Shea M, Mohede IC, Walaski HP, Atkinson RL: Safety profile of conjugated linoleic acid in a 12-month trial in obese humans. Food Chem Toxicol 2004;42:1701-1709.
56. Syvertsen C, Halse J, Hoivik HO, Gaullier JM, Nurminiemi M, Kristiansen K, Einerhand A, O'Shea M, Gudmundsen O: The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese. Int J Obes (Lond) 2007;31:1148-1154.
57. Yanagita T, Wang YM, Nagao K, Ujino Y, Inoue N: Conjugated linoleic acid-induced fatty liver can be attenuated by combination with docosahexaenoic acid in C57BL/6N mice. J Agric Food Chem 2005;53:9629-9633.
58. Purushotham A, Shrode GE, Wendel AA, Liu LF, Belury MA: Conjugated linoleic acid does not reduce body fat but decreases hepatic steatosis in adult Wistar rats. J Nutr Biochem 2007;18: 676-684.
59. Vella KR, Burnside AS, Brennan KM, Good DJ: Expression of the hypothalamic transcription factor Nhlh2 is dependent on energy availability. J Neuroendocrinol 2007;19:499-510.
60. Farooqi IS, O'Rahilly S: Monogenic obesity in humans. Annu Rev Med 2005;56:443-458.